{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:02:49Z","timestamp":1787061769416,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the effect of a web-based educational intervention on changing female college students\u2019 willingness and uptake of human papillomavirus (HPV) vaccines, and factors associated with HPV vaccination acceptance in Western and Northern China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A web-based cluster randomized controlled trial was conducted in Western and Northern China from February to May 2020. A total of 967 female freshmen were recruited from two universities through convenience sampling, stratified sampling (liberal arts or sciences), and cluster sampling. Eligible students were randomized into intervention and control group with a 1:1 allocation ratio. The intervention group received seven days of web-based health education regarding HPV and HPV vaccines, whereas the control group received non-HPV-related materials. All students were asked to complete a post-intervention questionnaire to measure their awareness, uptake, and willingness to receive HPV vaccination at 7-day and one-month intervals. The\n                      <jats:italic>chi<\/jats:italic>\n                      -square test and Student\u2019s\n                      <jats:italic>t-<\/jats:italic>\n                      test were employed to examine the differences between the intervention and control groups for categorical and continuous data. Logistic regressions were used to analyze factors associated with vaccination intentions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nine hundred forty-six female freshmen aged 18.99\u2009\u00b1\u20090.63\u00a0years were enrolled in the study, with 532 in the intervention group and 414 in the control group. Prior to the intervention, 63.8%, 66.3%, and 60.8% of students had heard of HPV, HPV-related diseases, and HPV vaccines, respectively. Only 2.2% of students reported being vaccinated, but 33.0% were willing to be vaccinated against HPV. After seven days of education, students in the intervention group exhibited higher awareness (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and knowledge scores (5.13\u2009\u00b1\u20091.23 vs. 3.10\u2009\u00b1\u20091.99,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) than those in the control group. Similarly, in the intervention groups, willingness to be vaccinated against HPV was significantly higher than in the control groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The high cost (57.7%) and concerns about adverse events (56.0%) were the main reasons female college students did not accept HPV vaccines. School location in urban areas, parents\u2019 higher education backgrounds, history of HPV vaccination counseling, history of sexual behavior, and having heard of HPV vaccines were associated with a higher willingness to be vaccinated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Female college students\u2019 HPV vaccination uptake is insufficient, and they have minimal detailed knowledge about HPV and its vaccines. Web-based health education on HPV vaccines is an easy, feasible, and effective way to improve the awareness and acceptance of HPV vaccination among female college students, but it has limited effect on HPV vaccination uptake.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-022-01625-0","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T04:04:35Z","timestamp":1645589075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Impact of web-based health education on HPV vaccination uptake among college girl students in Western and Northern China: a follow-up study"],"prefix":"10.1186","volume":"22","author":[{"given":"Xi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"issue":"3","key":"1625_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1625_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"WQ Chen","year":"2016","unstructured":"Chen WQ, Zheng RS, Baade PD, Zhang SW, Zeng HM, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"9895","key":"1625_CR3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889\u201399.","journal-title":"Lancet"},{"issue":"1","key":"1625_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12\u20139.","journal-title":"J Pathol"},{"issue":"1","key":"1625_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.vaccine.2020.11.029","volume":"39","author":"SY Hu","year":"2021","unstructured":"Hu SY, Xu XQ, Zhang YY, Liu YW, Yang CX, Wang YY, et al. A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: implications for vaccine roll-out in mainland China. Vaccine. 2021;39(1):35\u201344.","journal-title":"Vaccine"},{"issue":"10","key":"1625_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S2352-4642(18)30220-7","volume":"2","author":"MJ Silverberg","year":"2018","unstructured":"Silverberg MJ, Leyden WA, Lam JO, Gregorich SE, Huchko MJ, Kulasingam S, et al. Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study. Lancet Child Adolesc Health. 2018;2(10):707\u201314.","journal-title":"Lancet Child Adolesc Health"},{"key":"1625_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12879-015-0998-5","volume":"15","author":"R Wang","year":"2015","unstructured":"Wang R, Guo XL, Wisman GBA, Schuuring E, Wang WF, Zeng ZY, et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. BMC Infect Dis. 2015;15:257.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"1625_CR8","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1080\/21645515.2021.1899731","volume":"17","author":"G Yin","year":"2021","unstructured":"Yin G, Zhang YL, Chen CY, Ren HY, Guo BT, Zhang M. Have you ever heard of Human Papillomavirus (HPV) vaccine? The awareness of HPV vaccine for college students in China based on meta-analysis. Hum Vaccin Immunother. 2021;17(8):2736\u201347.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"1625_CR9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1080\/21645515.2020.1783952","volume":"17","author":"OG Chido-Amajuoyi","year":"2021","unstructured":"Chido-Amajuoyi OG, Jackson I, Yu R, Shete S. Declining awareness of HPV and HPV vaccine within the general US population. Hum Vaccin Immunother. 2021;17(2):420\u20137.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"1625_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/vaccines8010031","volume":"8","author":"DY You","year":"2020","unstructured":"You DY, Han LY, Li L, Hu JC, Zimet GD, Alias H, et al. Human papillomavirus (HPV) vaccine uptake and the willingness to receive the HPV vaccination among female college students in China: a multicenter study. Vaccines (Basel). 2020;8(1):31.","journal-title":"Vaccines (Basel)"},{"key":"1625_CR11","unstructured":"World Health Organization. Human papillomavirus (HPV) and cervical cancer. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/human-papillomavirus-(hpv)-and-cervical-cancer. In."},{"issue":"2","key":"1625_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/21645515.2020.1780093","volume":"17","author":"H Chen","year":"2021","unstructured":"Chen H, Zhang X, Wang W, Zhang R, Du M, Shan L, et al. Effect of an educational intervention on human papillomavirus (HPV) knowledge and attitudes towards HPV vaccines among healthcare workers (HCWs) in Western China. Hum Vaccin Immunother. 2021;17(2):443\u201350.","journal-title":"Hum Vaccin Immunother"},{"issue":"20","key":"1625_CR13","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1016\/j.vaccine.2020.03.032","volume":"38","author":"X Zhang","year":"2020","unstructured":"Zhang X, Liu CR, Wang ZZ, Ren ZF, Feng XX, Ma W, et al. Effect of a school-based educational intervention on HPV and HPV vaccine knowledge and willingness to be vaccinated among Chinese adolescents: a multi-center intervention follow-up study. Vaccine. 2020;38(20):3665\u201370.","journal-title":"Vaccine"},{"key":"1625_CR14","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1186\/1471-2458-13-916","volume":"13","author":"IJ Chang","year":"2013","unstructured":"Chang IJ, Huang R, He W, Zhang SK, Wang SM, Zhao FH, et al. Effect of an educational intervention on HPV knowledge and vaccine attitudes among urban employed women and female undergraduate students in China: a cross-sectional study. BMC Public Health. 2013;13:916.","journal-title":"BMC Public Health"},{"issue":"4","key":"1625_CR15","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.acap.2020.11.023","volume":"21","author":"FJ Real","year":"2021","unstructured":"Real FJ, Rosen BL, Bishop JM, McDonald S, DeBlasio D, Kreps GL, et al. Usability evaluation of the novel smartphone application, HPV vaccine: same way, same day, among pediatric residents. Acad Pediatr. 2021;21(4):742\u20139.","journal-title":"Acad Pediatr"},{"issue":"1","key":"1625_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12905-021-01417-y","volume":"21","author":"Q Wang","year":"2021","unstructured":"Wang Q, Zhang W. The use of Web-based interactive technology to promote HPV vaccine uptake among young females: a randomized controlled trial. BMC Womens Health. 2021;21(1):277.","journal-title":"BMC Womens Health"},{"issue":"4","key":"1625_CR17","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.vaccine.2019.11.028","volume":"38","author":"MA Gerend","year":"2020","unstructured":"Gerend MA, Murdock C, Grove K. An intervention for increasing HPV vaccination on a university campus. Vaccine. 2020;38(4):725\u20139.","journal-title":"Vaccine"},{"issue":"7","key":"1625_CR18","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1080\/21645515.2020.1852871","volume":"17","author":"AB Berenson","year":"2021","unstructured":"Berenson AB, Hirth JM, Chang M, Kuo YF, Richard P, Jones DL. A brief educational intervention can improve nursing students\u2019 knowledge of the human papillomavirus vaccine and readiness to counsel. Hum Vacc Immunother. 2021;17(7):1952\u201360.","journal-title":"Hum Vacc Immunother"},{"issue":"1","key":"1625_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s13187-018-1440-7","volume":"35","author":"SV Joshi","year":"2020","unstructured":"Joshi SV, Chaudhari HR, Chaudhari NA. Effect of education on awareness, knowledge, and willingness to be vaccinated in females of Western India. J Cancer Educ. 2020;35(1):61\u20138.","journal-title":"J Cancer Educ"},{"key":"1625_CR20","doi-asserted-by":"publisher","first-page":"106484","DOI":"10.1016\/j.ypmed.2021.106484","volume":"146","author":"XQ Xu","year":"2021","unstructured":"Xu XQ, Wang YY, Liu YW, Yu YQ, Yang CX, Zhang YY, et al. A nationwide post-marketing survey of knowledge, attitudes and recommendations towards human papillomavirus vaccines among healthcare providers in China. Prev Med. 2021;146:106484.","journal-title":"Prev Med"},{"key":"1625_CR21","doi-asserted-by":"crossref","unstructured":"Xu YH, Bi WS, Liu T, Jiang YX, Wang Q, Fan RR. Factors associated with intention of human papillomavirus vaccination among Chinese college students: implications for health promotion. Hum Vaccin Immunother. 2021:1\u20137.","DOI":"10.1080\/21645515.2021.2007014"},{"issue":"12","key":"1625_CR22","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1080\/21645515.2015.1070996","volume":"11","author":"RJ DiClemente","year":"2015","unstructured":"DiClemente RJ, Murray CC, Graham T, Still J. Overcoming barriers to HPV vaccination: a randomized clinical trial of a culturally-tailored, media intervention among African American girls. Hum Vaccin Immunother. 2015;11(12):2883\u201394.","journal-title":"Hum Vaccin Immunother"},{"issue":"7\u20138","key":"1625_CR23","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1080\/21645515.2019.1611157","volume":"15","author":"LP Wong","year":"2019","unstructured":"Wong LP, Han LY, Li H, Zhao JS, Zhao QJ, Zimet GD. Current issues facing the introduction of human papillomavirus vaccine in China and future prospects. Hum Vaccin Immunother. 2019;15(7\u20138):1533\u201340.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"1625_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12889-019-6823-0","volume":"19","author":"CR Liu","year":"2019","unstructured":"Liu CR, Liang H, Zhang X, Pu C, Li Q, Li QL, et al. Effect of an educational intervention on HPV knowledge and attitudes towards HPV and its vaccines among junior middle school students in Chengdu, China. BMC Public Health. 2019(1);19:488.","journal-title":"BMC Public Health"},{"issue":"9","key":"1625_CR25","doi-asserted-by":"publisher","first-page":"e44881","DOI":"10.1371\/journal.pone.0044881","volume":"7","author":"XH Gao","year":"2012","unstructured":"Gao XH, Wu Y, Zhang Y, Zhang NX, Tang J, Qiu J, et al. Effectiveness of school-based education on HIV\/AIDS knowledge, attitude, and behavior among secondary school students in Wuhan, China. PLoS One. 2012;7(9):e44881.","journal-title":"PLoS One"},{"issue":"1","key":"1625_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/21645515.2019.1638727","volume":"16","author":"YN Liu","year":"2020","unstructured":"Liu YN, Di N, Tao X. Knowledge, practice and attitude towards HPV vaccination among college students in Beijing, China. Hum Vaccin Immunother. 2020;16(1):116\u201323.","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"1625_CR27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/ijerph13050486","volume":"13","author":"VC Chiang","year":"2016","unstructured":"Chiang VC, Wong HT, Yeung PC, Choi YK, Fok MS, Mak OI, et al. Attitude, acceptability and knowledge of HPV vaccination among local university students in Hong Kong. Int J Environ Res Public Health. 2016;13(5):486.","journal-title":"Int J Environ Res Public Health"},{"issue":"38","key":"1625_CR28","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1016\/j.vaccine.2020.06.074","volume":"38","author":"PG Szilagyi","year":"2020","unstructured":"Szilagyi PG, Albertin CS, Gurfinkel D, Saville AW, Vangala S, Rice JD, et al. Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US. Vaccine. 2020;38(38):6027\u201337.","journal-title":"Vaccine"},{"issue":"1","key":"1625_CR29","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1186\/s12889-020-09962-1","volume":"20","author":"MN Sitaresmi","year":"2020","unstructured":"Sitaresmi MN, Rozanti NM, Simangunsong LB, Wahab A. Improvement of Parent\u2019s awareness, knowledge, perception, and acceptability of human papillomavirus vaccination after a structured-educational intervention. BMC Public Health. 2020;20(1):1836.","journal-title":"BMC Public Health"},{"issue":"5","key":"1625_CR30","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1111\/hsc.12974","volume":"28","author":"S Cocchio","year":"2020","unstructured":"Cocchio S, Bertoncello C, Baldovin T, Fonzo M, Bennici SE, Buja A, et al. Awareness of HPV and drivers of HPV vaccine uptake among university students: a quantitative, cross-sectional study. Health Soc Care Community. 2020;28(5):1514\u201324.","journal-title":"Health Soc Care Community"},{"issue":"9","key":"1625_CR31","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1080\/13691058.2013.807518","volume":"15","author":"JY Siu","year":"2013","unstructured":"Siu JY. Barriers to receiving human papillomavirus vaccination among female students in a university in Hong Kong. Cult Health Sex. 2013;15(9):1071\u201384.","journal-title":"Cult Health Sex"},{"issue":"2","key":"1625_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/jnci\/djz074","volume":"112","author":"YL Qiao","year":"2020","unstructured":"Qiao YL, Wu T, Li RC, Hu YM, Wei LH, Li CG, et al. Efficacy, safety, and immunogenicity of an escherichia coli-produced bivalent human papillomavirus vaccine: an interim analysis of a randomized clinical trial. J Natl Cancer Inst. 2020;112(2):145\u201353.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1625_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12916-018-1098-3","volume":"16","author":"T Harder","year":"2018","unstructured":"Harder T, Wichmann O, Klug SJ, van der Sande MAB, Wiese-Posselt M. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review. BMC Med. 2018;16(1):110.","journal-title":"BMC Med"},{"issue":"43","key":"1625_CR34","doi-asserted-by":"publisher","first-page":"5753","DOI":"10.1016\/j.vaccine.2017.05.069","volume":"35","author":"Human papillomavirus vaccines","year":"2017","unstructured":"Human papillomavirus vaccines. WHO position paper, May 2017\u2013Recommendations. Vaccine. 2017;35(43):5753\u20135.","journal-title":"Vaccine"},{"issue":"10","key":"1625_CR35","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s10067-017-3768-5","volume":"36","author":"M Mart\u00ednez-Lav\u00edn","year":"2017","unstructured":"Mart\u00ednez-Lav\u00edn M, Amezcua-Guerra L. Serious adverse events after HPV vaccination: a critical review of randomized trials and post-marketing case series. Clin Rheumatol. 2017;36(10):2169\u201378.","journal-title":"Clin Rheumatol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01625-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-022-01625-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01625-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T04:04:38Z","timestamp":1645589078000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-022-01625-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1625"],"URL":"https:\/\/doi.org\/10.1186\/s12905-022-01625-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-785616\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"assertion":[{"value":"6 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki. The study protocol was approved by both the Clinical Research Ethics Committee of Peking University Cancer Hospital (Approval Number: 2019KT65) and the Chinese Center for Disease Control and Preventive Institutional Review Board (Approval Number: 201918) prior to implementation. Informed consent was obtained from each participant prior to the baseline survey.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}